Heart Lung and Circulation, published by Elsevier Science Inc, is a premier peer-reviewed journal that focuses on the dynamic fields of cardiology, cardiovascular medicine, and pulmonary and respiratory medicine. With its ISSN 1443-9506 and E-ISSN 1444-2892, this journal has established itself as a significant contributor to the scientific community since its inception in 2000 and continues to publish cutting-edge research through 2024. Ranked in the Q2 category for both Cardiology and Pulmonary and Respiratory Medicine for 2023, it reflects a strong impact within its discipline. While the journal operates under a subscription model, it offers a comprehensive platform for disseminating significant developments, case studies, and reviews pertinent to practitioners, researchers, and students alike. The journal's focus on bridging the gaps in knowledge surrounding heart and lung physiology underscores its vital role in enhancing patient care and informing clinical practices.

The Archives of Cardiovascular Diseases, published by Elsevier Masson, stands as a leading journal in the field of cardiology and cardiovascular medicine, with an impressive impact factor that underscores its relevance and influence. This esteemed journal, recognized in the Q2 category for both cardiology and miscellaneous medicine, aims to disseminate groundbreaking research, innovative methodologies, and clinical advancements that can shape the future of cardiovascular health. With its diverse array of open access options, researchers and students alike have the ability to engage with high-quality content, ensuring that cutting-edge findings are accessible globally. Since its inception in 2008, the journal has actively contributed to the advancement of knowledge in cardiovascular diseases, fostering collaboration among clinicians, researchers, and educators. Headquartered in Paris, France, Archives of Cardiovascular Diseases remains committed to enhancing our understanding of cardiovascular health and improving patient outcomes worldwide.

Heart Views is a prestigious and influential journal dedicated to the field of cardiology and cardiovascular medicine, published by Wolters Kluwer Medknow Publications. With an Open Access model implemented since 2010, the journal ensures that its valuable research findings are accessible to a global audience, fostering knowledge dissemination and collaboration among researchers, professionals, and students alike. While the current impact factor is not specified, its commitment to quality and peer-reviewed content has established it as a significant resource within the cardiology community. The journal publishes a diverse array of articles, including original research, reviews, and clinical studies aimed at advancing the understanding and treatment of cardiovascular diseases. Heart Views serves as an essential platform for sharing innovative ideas and practices, thereby contributing to improved patient care and outcomes in the dynamic field of heart health.

JOURNAL OF INTERVENTIONAL CARDIOLOGY, published by Wiley-Hindawi, stands as a pivotal resource in the dynamic fields of Cardiology and Cardiovascular Medicine, as well as Radiology, Nuclear Medicine, and Imaging. With an esteemed Q2 ranking in both categories as of 2023, this journal fosters the dissemination of innovative findings and methodologies in interventional cardiology, bridging the gap between clinical practice and research. Since transitioning to Open Access in 2019, it enhances accessibility and encourages a broader reach for its audience of researchers, professionals, and students. With a wide-ranging scope that extends from its inception in 1988 through to 2024, the journal continually captures significant advancements and trends within the cardiovascular arena, ensuring it remains an essential tool for ongoing education and professional development.

Therapeutic Advances in Cardiovascular Disease, published by SAGE Publications Ltd, is an esteemed open-access journal dedicated to disseminating cutting-edge research in the fields of cardiology and cardiovascular medicine. With an ISSN of 1753-9447 and an E-ISSN of 1753-9455, this journal has positioned itself at the forefront of cardiovascular research since its inception in 2007. The journal has earned a Q2 ranking in both cardiology and pharmacology categories, reflecting its impactful contributions to the science and practice of cardiovascular health. Operating from the United Kingdom, Therapeutic Advances in Cardiovascular Disease provides researchers and practitioners with an accessible platform to share innovative findings and therapeutic strategies, particularly since adopting an open-access model in 2019. By fostering scholarly dialogue and collaboration among professionals, this journal plays a pivotal role in advancing our understanding of cardiovascular diseases and enhancing patient care.

Netherlands Heart Journal is a premier academic publication dedicated to advancing knowledge in the field of cardiology and cardiovascular medicine. Published by BOHN STAFLEU VAN LOGHUM BV, this journal has established itself as a critical platform for researchers, professionals, and students seeking to explore groundbreaking findings and innovative practices in cardiovascular health. With an ISSN of 1568-5888 and E-ISSN 1876-6250, the journal boasts a respectable Q2 ranking in the Cardiology and Cardiovascular Medicine category, placing it in the top half of its field according to the 2023 quartiles. The Scopus ranking places it 130th out of 387 in the relevant category, indicating a commendable percentile rank of 66th, which attests to its influence and quality of published research. Spanning from 2005 to 2024, the journal endeavors to include a diverse array of topics, encompassing clinical practice, technological innovations, and public health considerations related to cardiovascular diseases. Researchers and practitioners are encouraged to engage with the journal's robust content, contributing to and benefiting from the collaborative effort to enhance cardiovascular health worldwide.

EuroIntervention is a prestigious academic journal dedicated to the field of cardiology and cardiovascular medicine, published by EUROPA EDITION. Established as an essential resource for researchers and healthcare professionals, the journal holds an impressive Q1 ranking in both Cardiology and Cardiovascular Medicine as of 2023, demonstrating its influence and commitment to advancing knowledge in these fields. With an ISSN of 1774-024X and an E-ISSN of 1969-6213, EuroIntervention aims to publish high-quality research and clinical studies that address contemporary challenges in cardiovascular therapies. The journal is recognized for its rigorous peer-review process, ensuring that each article contributes valuable insights to the community. Researchers will find EuroIntervention a vital platform to disseminate their findings and engage with innovative cardiology techniques. Operating from France, the journal aspires to bridge the gap between research and clinical practice, making it an essential read for cardiologists, medical professionals, and students alike, keen to stay abreast of the latest advancements in cardiovascular care.

Revista Portuguesa de Cardiologia, published by Elsevier España SLU, stands as a pivotal resource in the realm of Cardiology and Cardiovascular Medicine. With its origins tracing back to 1970, this journal has cultivated a robust academic presence, achieving a 2023 Q3 ranking in its category, and currently holding a position of #220 out of 387 on the Scopus rankings, placing it within the 43rd percentile of its field. This open access journal, available since 2011, aims to disseminate high-quality research and insights relevant to contemporary cardiovascular issues. Its commitment to accessibility and knowledge exchange enhances its importance for clinicians, researchers, and students alike, fostering a more informed community in the fight against cardiovascular diseases. Operating from its base in Barcelona, Spain, the journal welcomes contributions that further the understanding and treatment of heart conditions, contributing significantly to the advancement of cardiovascular health.

The Journal of the Saudi Heart Association is a prominent scholarly publication dedicated to advancing knowledge in the fields of cardiology and cardiovascular medicine. Published by DIGITAL COMMONS BEPRESS, this open-access journal has been serving the global community since 2009, providing a vital platform for researchers, practitioners, and students interested in the latest developments in heart health and disease management. With an ISSN of 1016-7315 and a growing repository of knowledge alongside an E-ISSN of 2212-5043, the journal showcases an array of peer-reviewed articles that contribute to the understanding of cardiovascular conditions. Although categorized in the Q4 quartile for 2023, it remains committed to offering valuable insights, particularly within the constraints of the 29th percentile rank specified by Scopus. As the journal converges towards 2024, it continues to foster collaboration, innovation, and inquiry within the Saudi Arabian and international medical communities.

The Anatolian Journal of Cardiology, published by KARE PUBL, stands as a vital resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 2149-2263 and E-ISSN 2149-2271, this Open Access journal has been fostering the dissemination of critical research since 2001, ensuring that high-quality content is freely available to a global audience. Based in Turkey, the journal aims to bridge gaps in cardiological knowledge through rigorous peer-reviewed articles that span a wide range of topics, from innovative clinical practices to groundbreaking research findings. While its current ranking places it in the Q3 category of cardiology journals, the Anatolian Journal of Cardiology continues to strive towards enhancing its impact, currently holding a Scopus rank of 236 out of 387. Researchers, practitioners, and students alike will find this journal an essential platform for keeping abreast of the latest developments in cardiovascular health.